Global Stem Cell Cryopreservation Market Expected to Reach $10.17 Billion by 2030 with 19.5% CAGR

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Stem Cell Cryopreservation Market Over The Period 2026–2030?

The stem cell cryopreservation market has experienced swift expansion in recent years. Its valuation is projected to increase from $4.17 billion in 2025 to $4.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.8%. The historical growth in this sector is primarily linked to the expansion of stem cell banking initiatives, the increasing application of cryopreservation in research, a rise in IVF and fertility treatments, growing demand for long-term cell storage, and advancements in cryogenic storage technologies.

The stem cell cryopreservation market is anticipated to experience significant expansion in the next few years. It is projected to reach $10.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 19.5%. This growth over the forecast period can be attributed to the increasing uptake of regenerative medicine therapies, escalating investments in biobanking infrastructure, a rising need for personalized medicine storage solutions, the expansion of clinical cell therapy pipelines, and a greater emphasis on standardized storage protocols. Major trends during this period include an increasing demand for long-term stem cell storage, the growing utilization of advanced cryoprotectants, broader adoption of automated cryopreservation systems, the expansion of stem cell banking services, and an enhanced focus on preserving cell viability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30405&type=smp

What Drivers Are Expected To Influence The Stem Cell Cryopreservation Market During The Forecast Period?

The rising occurrence of degenerative diseases is anticipated to boost the expansion of the stem cell cryopreservation market in the future. These conditions involve the gradual worsening of tissue or organ structure or function over time, frequently resulting in a loss of normal capabilities. This rise in degenerative diseases is linked to an expanding elderly population, as older individuals are more prone to cellular and tissue damage that leads to such ailments. Stem cell cryopreservation offers the capability to store living stem cells for extended periods, serving as a dependable resource for regenerative treatments aimed at repairing and replacing compromised tissues in degenerative conditions. A relevant example is the Alzheimer’s Association, a US-based nonprofit voluntary health organization, which reported in March 2023 that approximately 6.7 million Americans aged 65 and above suffer from Alzheimer’s dementia, a figure expected to climb to 13.8 million by 2060. Consequently, the growing prevalence of degenerative diseases is a key factor propelling the expansion of the stem cell cryopreservation market.

How Is The Stem Cell Cryopreservation Market Divided Into Its Major Segments?

The stem cell cryopreservation market covered in this report is segmented –

1) By Type: Embryonic Stem Cell, Adult Stem Cell, Induced Pluripotent Stem Cell

2) By Application: Cell Freezing Media, Equipment And Consumables

3) By End User: Biopharmaceutical Companies, Research Institutes, Blood Banks, In Vitro Fertilization (IVF) Clinics

Subsegments:

1) By Embryonic Stem Cell: Human Embryonic Stem Cell, Mouse Embryonic Stem Cell, Primate Embryonic Stem Cell, Other Embryonic Stem Cells

2) By Adult Stem Cell: Hematopoietic Stem Cell, Mesenchymal Stem Cell, Neural Stem Cell, Epithelial Stem Cell

3) By Induced Pluripotent Stem Cell: Fibroblast-Derived iPSC, Blood Cell-Derived iPSC, Epithelial Cell-Derived iPSC

What Key Trends Are Influencing The Development Of The Stem Cell Cryopreservation Market?

Major entities operating within the stem cell cryopreservation market are dedicating efforts to developing inventive solutions, including sophisticated cryopreservation media and automation-compatible freezing systems. These innovations aim to improve post-thaw cell viability and expedite the advancement of stem cell therapies. Advanced cryopreservation media represent specially formulated compositions designed to safeguard stem cells during freezing and thawing, thereby preserving their viability and functionality, whereas automation-friendly freezing systems are equipment or methodologies engineered for scalable, reproducible, and autonomous freezing of cells in extensive manufacturing operations. For example, in April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze, its proprietary cryopreservation medium. This cutting-edge solution is specifically developed to optimize the freezing and thawing processes for pluripotent stem cells and other sensitive cell types, ensuring enhanced post-thaw viability and functional integrity. Characterized by an entirely synthetic, animal-origin-free formulation with low viscosity, PluriFreeze is optimally suited for automated and large-scale cell production. It is further enhanced by the DMSO-free PluriPrep wash solution, which enables extended processing times. Formulated from Generally Recognized as Safe (GRAS) components, this medium delivers consistent, reliable, and secure cryopreservation for both research and clinical applications. By seamlessly integrating with platforms such as PluriBank, this introduction fortifies the stem cell cryopreservation workflow, offering efficient and scalable solutions from initial laboratory research to full clinical implementation.

Who Are The Prominent Organizations Shaping The Stem Cell Cryopreservation Market?

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

Read the full stem cell cryopreservation market report here:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-cryopreservation-market-report

Which Region Is Forecast To Lead The Stem Cell Cryopreservation Market In Terms Of Market Size?

North America was the largest region in the stem cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Stem Cell Cryopreservation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30405&type=smp

Browse Through More Reports Similar to the Global Stem Cell Cryopreservation Market 2026, By The Business Research Company

Human Embryonic Stem Cells Global Market Report

https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cell And Gene Therapy Manufacturing Services Market

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795